Item 7.01 Regulation FD Disclosure.
Patterson Companies, Inc. (the "Company") will present virtually at the 2022
J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 9:00 a.m.
Eastern Time. A live webcast of the presentation, which will contain financial
and other information regarding the Company, will be available via
www.pattersoncompanies.com in the "Investors Relations" section. A replay will
be available on the Company's website following the presentation. The Company's
written presentation materials have been posted to the Company's website and are
furnished as Exhibit 99 to this Current Report on Form 8-K. The information set
forth therein is incorporated herein by reference and constitutes a part of this
report.
This information is furnished pursuant to Item 7.01 of Form 8-K promulgated by
the Securities and Exchange Commission (the "SEC") and shall not be deemed to be
"filed" with the SEC for the purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section, nor shall it be deemed to be incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such
filing. By filing this Current Report on Form 8-K and furnishing this
information, the Company makes no admission as to the materiality of any
information contained in this report.
Please refer to page 2 of the presentation attached hereto as Exhibit 99 for a
discussion of certain forward-looking statements included therein and the risks
and uncertainties related thereto.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99 Presentation by Patterson Companies, Inc. dated January 12, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses